In the U.S., emergency-use authorization has been granted for convalescent plasma, the efficacy of which is yet to be robustly tested. For some, this echoes the situation with hydroxychloroquine and the government’s subsequent U-turn on its rollout.
Meanwhile, America’s infection rate appears to be flattening out — but at tens of thousands of cases per day. ... Show More
Yesterday
A Week of Scandal, Reckoning and Resignations in Congress
Warning: This episode discusses suicide. This week, Congress was on the cusp of doing something that has never happened in U.S. history: forcibly removing four House members. Two of those members resigned. Michael Gold, who covers Congress, explains what unfolded on Capitol Hill, ... Show More
26m 21s
Apr 15
Trump’s Risky Strategy to Blockade Iran’s Blockade
Over a month into a war with Iran that has no clear end, President Trump has enforced a blockade, which went into effect on Monday at the Strait of Hormuz. The New York Times reporters David E. Sanger, Rebecca F. Elliott and Eric Schmitt discuss the strategy behind the blockade, ... Show More
27m 18s
Dec 2020
Vaccine hesitancy, the next pandemic hurdle
As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy.
Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More
31m 47s